Galectin Therapeutics
GALT
GALT
75 hedge funds and large institutions have $25.3M invested in Galectin Therapeutics in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 13 increasing their positions, 20 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
3.78% less ownership
Funds ownership: 17.41% → 13.62% (-3.8%)
35% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 20
Holders
75
Holding in Top 10
–
Calls
$1.8M
Puts
$737K
Top Buyers
| 1 | +$1.82M | |
| 2 | +$539K | |
| 3 | +$445K | |
| 4 |
HF
HRT Financial
New York
|
+$335K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$316K |
Top Sellers
| 1 | -$5.84M | |
| 2 | -$1.46M | |
| 3 | -$1.04M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$757K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$384K |